Moderna (MRNA) was on track to see a weekly gain of 21% as of Wednesday. Shares of the vaccine maker rose 11.7% the prior day following the first reported bird flu death in the US. The stock was up as ...

Moderna MRNA shares soared 11.7% in the last trading session to close at $47.53. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...

The death of a Louisiana resident and a severe infection involving a B.C. teen has experts worried about the emerging threat ...